**
Colossal Biosciences, a biotechnology firm based in Dallas, is at the forefront of a revolutionary initiative to bring extinct species back to life, notably the woolly mammoth and the dodo. With a valuation of $10.2 billion, the company has garnered both attention and criticism for its ambitious goals, which it frames as a moral imperative in response to the ongoing extinction crisis. Critics, however, question the integrity and implications of such endeavours, suggesting they may undermine conservation efforts.
The Drive for De-Extinction
The notion of resurrecting species that have been absent from the Earth’s ecosystems for millennia once seemed firmly rooted in the realm of science fiction. Yet, within a modest brick structure in a Dallas business park, Colossal Biosciences is actively attempting to realise this vision. The company made headlines last year when it announced the successful birth of dire wolf pups, a species absent for over 10,000 years, through advanced gene editing techniques involving ancient DNA. This feat has positioned Colossal as a pioneering force in “de-extinction” efforts.
Colossal’s CEO, Ben Lamm, embraces comparisons to the cinematic world of *Jurassic Park*, acknowledging its influence on public awareness regarding DNA and genetic modification. “I don’t mind the Jurassic Park comparison because we get it a lot,” he stated, emphasising the positive dialogue it has generated about genetic science.
The Science Behind the Ambition
The company’s 55,000 square foot facility is the heart of its groundbreaking research, where scientists employ cutting-edge CRISPR technology to edit the genomes of existing animals, aiming to emulate the traits of their extinct relatives. For instance, the dire wolf’s genetic structure was altered by modifying 14 genes from the grey wolf to produce a hybrid that boasts distinct physical characteristics, such as a larger frame and enhanced cold resistance.
Colossal’s aspirations extend to reviving other extinct species, including the thylacine, or Tasmanian tiger, last seen in 1936. The challenge of recreating the thylacine, however, is significant; it requires an estimated million genetic modifications to achieve a comparable appearance and functionality using the fat-tailed dunnart as a genetic template.
Ethical Implications and Criticism
Despite the excitement surrounding Colossal’s ambitions, the scientific community is divided. Critics argue that the company is not truly resurrecting species but instead creating genetically modified versions, a sentiment echoed by Vincent Lynch, an expert in evolutionary biology, who stated, “They made genetically modified grey wolves, not dire wolves. To say they are dire wolves is entirely arrogant.”
The philosophical debate surrounding what defines a species complicates the conversation further. Lynch contends that Colossal’s definitions harken back to outdated notions. Questions arise about the ecological roles that these revived species would play in modern ecosystems, which have evolved significantly since their original existence.
A Cautious Approach to Revival
The potential introduction of de-extinct species into contemporary environments raises concerns about ecological balance and the unforeseen consequences of such actions. Julie Meachen, a paleontologist, warns that reintroducing mammoths into areas like Alaska could lead to significant disruption, particularly in proximity to human settlements. “If they come into town will you shoot them? If they are instead held in a glorified zoo will you just sell tickets to rich people to ogle them?” she questioned, highlighting the complexities of cohabitation with these revived creatures.
Furthermore, the concept of ‘moral hazard’ emerges in this discourse. Critics worry that the prospect of de-extinction could diminish the urgency for habitat preservation and the protection of endangered species. As Doug Burgum, former Secretary of the Interior, suggested, if species can be resurrected, why prioritise current conservation efforts?
Why it Matters
Colossal Biosciences’ quest to resurrect lost species is more than a scientific endeavour; it is a profound exploration of our relationship with nature and the ethical boundaries of technology. While the allure of bringing back iconic species captures the public’s imagination, it also risks overshadowing the essential work needed to protect existing wildlife. The implications of these efforts could redefine conservation strategies and challenge our understanding of biodiversity. As we stand at this crossroads, it is crucial to engage in thoughtful dialogue about the future of our planet’s ecosystems, balancing innovation with responsibility.
